Pronalis Tapfumaneyi | Toxicology and Pharmaceutical Science | Best Researcher Award

Datlabs Pvt Ltd|Zimbabwe

Pronalis Tapfumaneyi is a dedicated pharmacist and researcher with a strong background in public health and pharmaceutics. She’s currently pursuing her Master’s in Public Health at Africa University and has a Master’s degree in Pharmaceutics from Rhodes University, where she graduated with distinction. Pronalis has experience in regulatory affairs, clinical research, and community service, and is committed to improving healthcare outcomes.

Publication Profile

Orcid

Education

Master of Public Health (MPH): Pronalis is currently pursuing her MPH degree at Africa University, focusing on public health aspects that can significantly impact communities.Master of Science (MSc) in Pharmaceutics: She earned her MSc degree in Pharmaceutics from Rhodes University, where she graduated with distinction. Her research expertise in pharmaceutics has equipped her with a deep understanding of drug development and delivery systems. Bachelor of Pharmacy (BPharm): Pronalis completed her BPharm degree at Rhodes University, laying a solid foundation for her future academic and professional pursuits in pharmacy and public health. Her academic achievements demonstrate her commitment to excellence in her field, and her research experience has prepared her to tackle complex problems in public health and pharmaceutics.

Experience

 Regulatory Affairs Pharmacist: Currently, Pronalis serves as a Regulatory Affairs Pharmacist at Datlabs (Pvt) Ltd, where she ensures compliance with regulatory requirements and oversees the development of new products. Regulatory Officer: Pronalis has also worked as a Regulatory Officer at the Medicines Control Authority of Zimbabwe, where she evaluated dossiers for regulatory compliance and issued registration certificates for medicines. Clinical Study Coordinator and Technician: At the Biopharmaceutics Research Institute, Pronalis coordinated clinical studies, managed study documents, and performed data analysis. Retail Pharmacist: Additionally, Pronalis has experience as a Retail Pharmacist at Medpoint Pharmacy, where she dispensed prescriptions, conducted health screenings, and advised patients on medication use. These experiences have equipped Pronalis with a broad understanding of the pharmaceutical industry, from research and development to regulatory affairs and patient care.

Honors and Awards

Dean’s Academic Merit List: Pronalis has been recognized for her outstanding academic performance, being included on the Dean’s Academic Merit List for her exceptional grades and scholarly contributions. Master of Science with distinction: She graduated with distinction in her Master of Science program, highlighting her academic excellence and research capabilities in her field. National Research Foundation (NRF) Innovation Scholarship: Pronalis was awarded a prestigious scholarship by the NRF to support her research endeavors, acknowledging her potential to make significant contributions to her field. Biopharmaceutics Research Institute Scholarship: She received a scholarship from the Biopharmaceutics Research Institute, further underscoring her research potential and academic achievements. Golden Key International Honor Society membership: Pronalis is a member of the Golden Key International Honor Society, an esteemed organization that recognizes academic excellence and leadership potential.

Research Focus

Public Health: Pronalis’s research in public health is geared towards understanding and addressing health challenges at the community level. This includes exploring strategies to enhance healthcare delivery, improve patient safety, and promote overall well-being. Pharmaceutics: Her work in pharmaceutics involves the study of drug formulation, delivery systems, and pharmacokinetics. Pronalis aims to develop effective and safe pharmaceutical products that meet the needs of diverse patient populations. Regulatory Affairs: Pronalis’s expertise in regulatory affairs ensures that pharmaceutical products and healthcare practices comply with relevant laws, regulations, and standards. This includes evaluating dossiers for regulatory compliance and ensuring that products meet safety and efficacy requirements. A significant aspect of her current research is her ongoing dissertation project, which investigates factors associated with reporting of adverse drug events among healthcare workers in Harare city polyclinics. Identify barriers and facilitators: Pronalis seeks to understand the factors that influence healthcare workers’ reporting of adverse drug events, including potential barriers and facilitators.

Publications

Solute–Vehicle–Skin Interactions and Their Contribution to Pharmacokinetics of Skin Delivery, which explores the delicate balance between      molecular properties of drugs, skin properties, and formulation properties in percutaneous absorption.
Science of, and insights into, thermodynamic principles for dermal formulations, published in Drug Discovery Today.
The Pandemic and Your Skin – Direct and Indirect Impact of COVID-19, examining the effects of COVID-19 on skin health.
Fitting Pharmacodynamic Data to the Emax Model to Assess the Inherent Potency of Topical Corticosteroids, a study on assessing potency of    topical corticosteroids.
Recent Advances and Future Prospective of Topical and Transdermal Delivery Systems, discussing advancements in topical and transdermal    drug delivery systems.